Tamoxifen 20 mg

DRUG6 trials

Sponsors

Pfizer, Assiut University, Institut Cancerologie de l'Ouest, Karolinska University Hospital, Fudan University

Conditions

Breast CancerBreast CarcinomaBreast NeoplasmsBreast TumorsCancer of BreastDuctal Carcinoma in SituExtensive DiseaseHealthy

Phase 1

A Study To Determine If Coadministration Of Tamoxifen Alters The Extent Or Rate Of Palbociclib (PD-0332991) Absorption Or Elimination In Healthy Male Volunteers

CompletedNCT01821066

Start: 2013-04-30End: 2013-08-31Updated: 2015-10-08

Phase 2

Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ

RecruitingNCT04666961

Institut Cancerologie de l'OuestDuctal Carcinoma in Situ, Extensive Disease, Mastectomy

Start: 2021-02-03End: 2033-08-01Target: 262Updated: 2022-04-22

Therapeutic Dose Monitoring (TDM) of Tamoxifen

Karolinska University HospitalBreast Cancer, Breast Carcinoma, Breast Tumors +2

Start: 2022-04-04End: 2023-03-01Updated: 2022-05-25

Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas

RecruitingNCT06914674

Fudan UniversityPancreatic Neoplasms

Start: 2025-03-20End: 2028-02-28Target: 30Updated: 2025-04-06

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

Not yet recruitingNCT07287098

Eli Lilly and CompanyBreast Neoplasms

Start: 2026-05-01End: 2029-12-01Target: 600Updated: 2026-03-27

Unknown Phase

Genetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen

Assiut UniversityBreast Cancer

Start: 2019-09-01End: 2020-12-31Target: 100Updated: 2019-07-08